Free Trial

Aurora Cannabis Q4 2024 Earnings Report

Aurora Cannabis logo
C$6.93 -0.10 (-1.42%)
As of 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
C$0.14
Consensus EPS
-C$0.24
Beat/Miss
Beat by +C$0.38
One Year Ago EPS
N/A

Aurora Cannabis Revenue Results

Actual Revenue
$67.41 million
Expected Revenue
$69.30 million
Beat/Miss
Missed by -$1.89 million
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Q4 2024
Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Is Aurora Cannabis stock a good buy right now?
77 Hedge Funds Are Betting On This Off-Radar Mineral
With surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fact, 77 hedge funds have quietly increased their positions, pouring millions into companies poised to capitalize on this essential commodity. The reason is simple: America currently depends on Canada for 80% of its potash supply.
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile

More Earnings Resources from MarketBeat